Chinese Biotech Firm Denovo Biopharma Nets $42M In Series B Round

Denovo Biopharma, a Chinese biotechnology company providing a novel biomarker solution to personalize drug development, has raised RMB300 million (US$42.6 million) in a series B round of financing, according to a statement released on Thursday. Investors of this round include the country‚Äôs investment firm Jiuyou Capital, Sangel Venture Capital, Share Capital, Zheshang Industrial Integration Asset […]

Chinese Biotech Firm Denovo Biopharma Nets $42M In Series B Round comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network